Schrodinger Inc’s stock has reached a new 52-week low, closing at 13.43 USD. This marks a significant downturn for the company, which has seen its stock value decrease by 43% over the past year.

A hundred years ago this week, at the height of the quantum revolution, Austrian physicist Erwin Schrödinger submitted a manuscript for publication. Its centerpiece was an innocuous-looking equation ...

Schrodinger Inc’s stock reached a 52-week low, hitting $15.97, marking a significant downturn for the company. According to InvestingPro data, the stock is currently trading just 1% above its 52-week ...

Schrödinger’s cat just got a little bit fatter. Physicists have created the largest ever ‘superposition’ — a quantum state in which an object exists in a haze of possible locations at once. A team ...

Schrödinger (SDGR) has drawn investor attention after recent share price moves, with the stock last closing at US$18.64. That puts the company’s recent performance and underlying fundamentals back in ...

Jan 9 (Reuters) - Schrodinger (SDGR.O), opens new tab said on Friday it is collaborating with Eli Lilly (LLY.N), opens new tab to offer the pharmaceutical major's AI-based platform, TuneLab, on its ...

Aug 14 (Reuters) - Schrödinger (SDGR.O), opens new tab said on Thursday it has stopped the development of an experimental drug after the death of two patients with a type of blood cancer in an ...

Schrödinger has halted development of its cancer-fighting candidate SGR-2921 after two patients treated with the cell division cycle 7 (CDC7) inhibitor died in a Phase I trial. The trial (NCT05961839) ...

Think Portal with cats. Meet Mittens in Schrodinger's Cat Burglar, a (literal) cat burglar whose heist goes wrong – and traps her in a quantum experiment, with a newfound ability to be in two places ...

Schrödinger delivered strong Q1 results, with robust software growth and improving margins, despite a tough macro environment. Regulatory changes, especially the FDA's move away from animal testing, ...

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR) today announced that the company and Geoffrey Porges, MBBS., have mutually agreed that Dr. Porges will depart from his role as chief financial ...